Shehnaaz Suliman, Director, on September 22, 2026, sold 5,723 shares in 10x Genomics (TXG) for $464,668. Following the Form 4 filing with the SEC, Suliman has control over a total of 23,792 Class A common shares of the company, with 23,792 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1770787/000161071726000422/xslF345X05/form4.xml